TY - JOUR AU - Auerbach, W. AU - Auerbach, R. PY - 1994 DA - 1994// TI - Angiogenesis inhibition: a review. [Review] [436 refs] JO - Pharmacol Ther VL - 63 UR - https://doi.org/10.1016/0163-7258(94)90027-2 DO - 10.1016/0163-7258(94)90027-2 ID - Auerbach1994 ER - TY - JOUR AU - Bisacchi, D. AU - Benelli, R. AU - Vanzetto, C. AU - Ferrari, N. AU - Tosetti, F. AU - Albini, A. PY - 2003 DA - 2003// TI - Anti-angiogenesis and angioprevention: mechanisms, problems and perspectives. [Review] [122 refs] JO - Cancer Detection & Prevention VL - 27 UR - https://doi.org/10.1016/S0361-090X(03)00030-8 DO - 10.1016/S0361-090X(03)00030-8 ID - Bisacchi2003 ER - TY - JOUR AU - Camp-Sorrell, D. PY - 2003 DA - 2003// TI - Antiangiogenesis: the fifth cancer treatment modality?. [Review] [61 refs] JO - Oncology Nursing Forum VL - 30 UR - https://doi.org/10.1188/03.ONF.934-944 DO - 10.1188/03.ONF.934-944 ID - Camp-Sorrell2003 ER - TY - JOUR AU - Ciardella, A. P. AU - Donsoff, I. M. AU - Guyer, D. R. AU - Adamis, A. AU - Yannuzzi, L. A. PY - 2002 DA - 2002// TI - Antiangiogenesis agents. [Review] [69 refs] JO - Ophthalmology Clinics of North America VL - 15 UR - https://doi.org/10.1016/S0896-1549(02)00042-1 DO - 10.1016/S0896-1549(02)00042-1 ID - Ciardella2002 ER - TY - JOUR AU - Longoria, R. L. AU - Cox, M. C. AU - Figg, W. D. PY - 2005 DA - 2005// TI - Antiangiogenesis: a possible treatment option for prostate cancer?. [Review] [86 refs] JO - Clinical Genitourinary Cancer VL - 4 UR - https://doi.org/10.3816/CGC.2005.n.033 DO - 10.3816/CGC.2005.n.033 ID - Longoria2005 ER - TY - JOUR AU - Harris, A. L. PY - 1998 DA - 1998// TI - Anti-angiogenesis therapy and strategies for integrating it with adjuvant therapy. [Review] [81 refs] JO - Recent Results in Cancer Research VL - 152 UR - https://doi.org/10.1007/978-3-642-45769-2_33 DO - 10.1007/978-3-642-45769-2_33 ID - Harris1998 ER - TY - CHAP AU - Hu, M. AU - Yang, J. L. AU - Teng, H. AU - Jia, Y. Q. AU - Wang, R. AU - Zhang, X. W. AU - Wu, Y. AU - Luo, Y. AU - Chen, X. C. AU - Zhang, R. AU - Tian, L. AU - Zhao, X. AU - Wei, Y. Q. PY - 2008 DA - 2008// TI - Anti-angiogenesis therapy based on the bone marrow-derived stromal cells genetically engineered to express sFlt-1 in mouse tumor model BT - Bmc Cancer ID - Hu2008 ER - TY - STD TI - Ma J, Chen CS, Blute T, Waxman DJ: Antiangiogenesis enhances intratumoral drug retention. Cancer Res. , 71: 2675-2685. ID - ref8 ER - TY - JOUR AU - Ebos, J. M. AU - Lee, C. R. AU - Bogdanovic, E. AU - Alami, J. AU - Van Slyke, P. AU - Francia, G. AU - Xu, P. AU - Mutsaers, A. J. AU - Dumont, D. J. AU - Kerbel, R. S. PY - 2008 DA - 2008// TI - Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-07-3217 DO - 10.1158/0008-5472.CAN-07-3217 ID - Ebos2008 ER - TY - JOUR AU - Conti, C. J. PY - 2002 DA - 2002// TI - Vascular endothelial growth factor: regulation in the mouse skin carcinogenesis model and use in antiangiogenesis cancer therapy. [Review] [97 refs] JO - Oncologist VL - 3 UR - https://doi.org/10.1634/theoncologist.7-suppl_3-4 DO - 10.1634/theoncologist.7-suppl_3-4 ID - Conti2002 ER - TY - STD TI - Schenone S, Bondavalli F, Botta M: Antiangiogenic agents: an update on small molecule VEGFR inhibitors. [Review] [194 refs]. Curr Med Chem. 14: 2495-2516. 2495 ID - ref11 ER - TY - JOUR AU - Rahimi, N. PY - 2006 DA - 2006// TI - VEGFR-1 and VEGFR-2: two non-identical twins with a unique physiognomy. [Review] [80 refs] JO - Front Biosci VL - 11 UR - https://doi.org/10.2741/1839 DO - 10.2741/1839 ID - Rahimi2006 ER - TY - JOUR AU - Petersen, I. PY - 2007 DA - 2007// TI - Antiangiogenesis, anti-VEGF(R) and outlook. [Review] [38 refs] JO - Recent Results in Cancer Research VL - 176 UR - https://doi.org/10.1007/978-3-540-46091-6_16 DO - 10.1007/978-3-540-46091-6_16 ID - Petersen2007 ER - TY - JOUR AU - Holmes, K. AU - Roberts, O. L. AU - Thomas, A. M. AU - Cross, M. J. PY - 2003 DA - 2003// TI - Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. [Review] [112 refs] JO - Cell Signal VL - 19 UR - https://doi.org/10.1016/j.cellsig.2007.05.013 DO - 10.1016/j.cellsig.2007.05.013 ID - Holmes2003 ER - TY - JOUR AU - Wang, R. AU - Zhang, X. W. AU - Wang, G. Q. AU - Chen, X. C. AU - Tian, L. AU - Yang, H. S. AU - Hu, M. AU - Peng, F. AU - Yang, J. L. AU - He, Q. M. AU - Zhang, W. AU - Jiang, Y. AU - Deng, H. X. AU - Wen, Y. J. AU - Li, J. AU - Zhao, X. AU - Wei, Y. Q. PY - 2006 DA - 2006// TI - Systemic inhibition of tumor growth by soluble Flk-1 gene therapy combined with cisplatin JO - Cancer Gene Therapy VL - 13 UR - https://doi.org/10.1038/sj.cgt.7700958 DO - 10.1038/sj.cgt.7700958 ID - Wang2006 ER - TY - STD TI - Millauer B, Longhi MP, Plate KH, Shawver LK, Risau W, Ullrich A, Strawn LM: Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo. Cancer Res. 56: 1615-1620. 1615 ID - ref16 ER - TY - JOUR AU - Jia, L. J. AU - Hua, Z. C. PY - 2009 DA - 2009// TI - Development of bacterial vectors for tumor-targeted gene therapy. [Review] [108 refs] JO - Methods in Molecular Biology VL - 542 UR - https://doi.org/10.1007/978-1-59745-561-9_7 DO - 10.1007/978-1-59745-561-9_7 ID - Jia2009 ER - TY - JOUR AU - Fujimori, M. AU - Amano, J. AU - Taniguchi, S. PY - 2002 DA - 2002// TI - The genus Bifidobacterium for cancer gene therapy. [Review] [25 refs] JO - Current Opinion in Drug Discovery & Development VL - 5 ID - Fujimori2002 ER - TY - STD TI - Chinnasamy D, Yu Z, Theoret MR, Zhao Y, Shrimali RK, Morgan RA, Feldman SA, Restifo NP, Rosenberg SA: Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice. J Clin Invest. 120: 3953-3968. 3953 ID - ref19 ER - TY - JOUR AU - Fujimori, M. PY - 2006 DA - 2006// TI - Genetically engineered bifidobacterium as a drug delivery system for systemic therapy of metastatic breast cancer patients. [Review] [23 refs] JO - Breast Cancer VL - 13 UR - https://doi.org/10.2325/jbcs.13.27 DO - 10.2325/jbcs.13.27 ID - Fujimori2006 ER - TY - JOUR AU - Noma, H. AU - Funatsu, H. AU - Mimura, T. AU - Eguchi, S. AU - Shimada, K. PY - 2011 DA - 2011// TI - Role of soluble vascular endothelial growth factor receptor-2 in macular oedema with central retinal vein occlusion JO - Br J Ophthalmol VL - 95 UR - https://doi.org/10.1136/bjo.2010.192468 DO - 10.1136/bjo.2010.192468 ID - Noma2011 ER - TY - JOUR AU - Yi, C. AU - Huang, Y. AU - Guo, Z. Y. AU - Wang, S. R. PY - 2005 DA - 2005// TI - Antitumor effect of cytosine deaminase/5-fluorocytosine suicide gene therapy system mediated by Bifidobacterium infantis on melanoma JO - Acta Pharmacol Sin VL - 26 UR - https://doi.org/10.1111/j.1745-7254.2005.00094.x DO - 10.1111/j.1745-7254.2005.00094.x ID - Yi2005 ER - TY - JOUR AU - Mao, S. H. AU - Ji, L. L. AU - Liu, H. AU - Xu, Y. Z. AU - Huang, H. AU - Huang, Y. AU - Yi, C. PY - 2009 DA - 2009// TI - [Cloning and prokaryotic expression of Bifidobacterium infantis-mediated sKDR and its effect on proliferation of vascular endothelial cells]. [Chinese] JO - Sichuan da Xue Xue Bao. Yi Xue Ban/Journal of Sichuan University. Medical Science Edition VL - 40 ID - Mao2009 ER - TY - JOUR AU - Bo, L. i. u. a. AU - Xiao-Chun, P. e. n. g. AU - Zheng, X. -. L. PY - 2009 DA - 2009// TI - MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo JO - Lung Cancer VL - 66 UR - https://doi.org/10.1016/j.lungcan.2009.01.010 DO - 10.1016/j.lungcan.2009.01.010 ID - Bo2009 ER - TY - JOUR AU - Cruz-Orive, L. M. PY - 2004 DA - 2004// TI - Precision of the fractionator from Cavalieri designs JO - J Microsc VL - 213 UR - https://doi.org/10.1111/j.1365-2818.2004.01291.x DO - 10.1111/j.1365-2818.2004.01291.x ID - Cruz-Orive2004 ER - TY - JOUR AU - Adler, D. D. AU - Carson, P. L. AU - Rubin, J. M. AU - Q-R, D. PY - 1990 DA - 1990// TI - Doppler ultrasound color flow imaging in the study of breast cancer; Preliminary findings JO - Ultrasound Med Biol VL - 16 UR - https://doi.org/10.1016/0301-5629(90)90020-D DO - 10.1016/0301-5629(90)90020-D ID - Adler1990 ER - TY - CHAP AU - Liu, T. G. AU - Huang, Y. AU - Cui, D. D. AU - Huang, X. B. AU - Mao, S. H. AU - Ji, L. L. AU - Song, H. B. AU - Yi, C. PY - 2009 DA - 2009// TI - Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice BT - Bmc Cancer ID - Liu2009 ER - TY - JOUR AU - Wang, M. AU - Tang, J. AU - Liu, S. AU - Yoshida, D. AU - Teramoto, A. PY - 2005 DA - 2005// TI - Expression of cathepsin B and microvascular density increases with higher grade of astrocytomas JO - J Neurooncol VL - 71 UR - https://doi.org/10.1007/s11060-004-9163-5 DO - 10.1007/s11060-004-9163-5 ID - Wang2005 ER - TY - JOUR AU - Kong, H. L. AU - Crystal, R. G. PY - 1998 DA - 1998// TI - Gene therapy strategies for tumor antiangiogenesis. [Review] [224 refs] JO - Journal of the National Cancer Institute VL - 90 UR - https://doi.org/10.1093/jnci/90.4.273 DO - 10.1093/jnci/90.4.273 ID - Kong1998 ER - TY - JOUR AU - Hu, B. AU - Kou, L. AU - Li, C. AU - Zhu, L. P. AU - Fan, Y. R. AU - Wu, Z. W. AU - Wang, J. J. AU - Xu, G. X. PY - 2009 DA - 2009// TI - Bifidobacterium longum as a delivery system of TRAIL and endostatin cooperates with chemotherapeutic drugs to inhibit hypoxic tumor growth JO - Cancer Gene Therapy VL - 16 UR - https://doi.org/10.1038/cgt.2009.7 DO - 10.1038/cgt.2009.7 ID - Hu2009 ER - TY - JOUR AU - Kaliberov, S. A. AU - Kaliberova, L. N. AU - Buchsbaum, D. J. PY - 2005 DA - 2005// TI - Combined ionizing radiation and sKDR gene delivery for treatment of prostate carcinomas JO - Gene Therapy VL - 12 UR - https://doi.org/10.1038/sj.gt.3302432 DO - 10.1038/sj.gt.3302432 ID - Kaliberov2005 ER - TY - JOUR AU - Yazawa, K. AU - Fujimori, M. AU - Nakamura, T. AU - Sasaki, T. AU - Amano, J. AU - Kano, Y. AU - Taniguchi, S. PY - 2001 DA - 2001// TI - Bifidobacterium longum as a delivery system for gene therapy of chemically induced rat mammary tumors JO - Breast Cancer Research & Treatment VL - 66 UR - https://doi.org/10.1023/A:1010644217648 DO - 10.1023/A:1010644217648 ID - Yazawa2001 ER - TY - JOUR AU - Kimura, N. T. AU - Taniguchi, S. AU - Aoki, K. AU - Baba, T. PY - 2061 DA - 2061// TI - Selective localization and growth of Bifidobacterium bifidum in mouse tumors following intravenous administration JO - Cancer Res VL - 40 ID - Kimura2061 ER - TY - JOUR AU - Yazawa, K. AU - Fujimori, M. AU - Amano, J. AU - Kano, Y. AU - Taniguchi, S. PY - 2000 DA - 2000// TI - Bifidobacterium longum as a delivery system for cancer gene therapy: selective localization and growth in hypoxic tumors JO - Cancer Gene Therapy VL - 7 UR - https://doi.org/10.1038/sj.cgt.7700122 DO - 10.1038/sj.cgt.7700122 ID - Yazawa2000 ER - TY - JOUR AU - Yasui, H. PY - 1991 DA - 1991// TI - Enhancement of immune response in Peyer’s patch cells cultured with Bifidobacterium breve JO - J Dairy Sci VL - 74 UR - https://doi.org/10.3168/jds.S0022-0302(91)78272-6 DO - 10.3168/jds.S0022-0302(91)78272-6 ID - Yasui1991 ER - TY - JOUR AU - Yazawa, K. AU - Fujimori, M. AU - Amano, J. AU - Kano, Y. AU - Taniguchi, S. PY - 2000 DA - 2000// TI - Bifidobacterium longum as a delivery system for cancer gene therapy: Selective localization and growth in hypoxic tumors JO - Cancer Gene Ther VL - 7 UR - https://doi.org/10.1038/sj.cgt.7700122 DO - 10.1038/sj.cgt.7700122 ID - Yazawa2000 ER - TY - JOUR AU - Xi, L. i. AU - Geng-Feng, F. u. AU - Yan-Rong, F. a. n. PY - 2003 DA - 2003// TI - Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: Selective inhibitor of angiogenesis and hypoxic tumor growth JO - Cancer Gene Ther VL - 10 UR - https://doi.org/10.1038/sj.cgt.7700530 DO - 10.1038/sj.cgt.7700530 ID - Xi2003 ER - TY - JOUR AU - Roeckl, W. AU - Hecht, D. AU - Sztajer, H. AU - Waltenberger, J. AU - Yayon, A. AU - Weich, H. A. PY - 1998 DA - 1998// TI - Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2 JO - Exp Cell Res VL - 241 UR - https://doi.org/10.1006/excr.1998.4039 DO - 10.1006/excr.1998.4039 ID - Roeckl1998 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/12/155/prepub UR - http://www.biomedcentral.com/1471-2407/12/155/prepub ID - ref39 ER -